Τελευταία νέα
HomeColumnsFeatured ArticlesA peptide for reducing anxiety – Selank
Featured articles

A peptide for reducing anxiety – Selank

An estimated 40 million persons over the age of 18 in the United States suffer from an anxiety condition, or 18.1 percent of the population, every year.

Regardless of our degree of success, all of us experience anxiety and stress at some point.

There is nothing more universal than anxiety, whether you're worried about a little matter or coping with a life-altering event. Not to mention the prevalence of anxiety in people with mental illness:

An estimated 40 million persons over the age of 18 in the United States suffer from an anxiety condition, or 18.1 percent of the population, every year. Only 36.9 percent of people with anxiety disorders obtain treatment, even though anxiety disorders are highly curable. Buy Selank peptide online in USA if you are a researcher.

Perhaps there is an alternate route to a quiet and peaceful mental state? One of the world's finest peptide doctors informed the world that "possibly replacing stimulant, tranquilizer, and antidepressant medications" could be achieved with one peptide.

Although Selank is commonly used in Russia, it is almost entirely unknown to Western doctors. You're at the right place if you're interested in learning more about Selank and how the Russians have discovered its anti-anxiety benefits.

What is Selank, and how does it differ from the other peptides
Tuftsin (also known as Selank) is an amino acid-rich peptide found in the human body that has been artificially synthesized.

To enhance the phagocytic activity of polymorphic leukocytes, Tuftsin, which is generated from the heavy chain of human immunoglobulin, is a tetrapeptide (Thr–Lys–Pro–Arg). Tuftsin was named after Tufts University since it was found at that institution.

Gamma-globulin, which covers the polymorph, is activated in the spleen and attached to a carrier leukocidin molecule. Tuftsin is an essential component of a healthy immune system.

However, Soviet scientists working at the Institute for Molecular Genetics of the Russian Academy of Sciences were intrigued by Tuftsin's effects on the central nervous system.

Valdman and Ashmarin proposed in the early 1980s that Tuftsin, a peripheral immune system regulator with structural similarities to a family of neuropeptides, affected the central nervous system.

It's important to note that natural peptides are very unstable when administered intravenously and have a short-lived impact. Russian scientists studied the synthesis and long-term effects of tuftsin analogs in great depth.

Pro-Gly-Pro-Pro-Arg-Pro-Gly-Pro was added to the heptapeptide to make it more stable and resistant to protease degradation. This combination was shown to be the most effective for stabilizing and resisting protease degradation.

The Russian Federation Ministry of Health has licensed Selank for human use in treating generalized anxiety disorder (GAD) since 2009. Despite this, the US Food and Drug Administration is unlikely to notice it shortly. If you look outside the Eastern Bloc, you'll only find Selank in research chemical form, not for human use, in Ukraine and other Eastern Bloc nations.

What Is the Process of Selank
It is based on reducing enkephalin degradation. According to what researchers now know about brain chemistry, the neuropeptide enkephalin may have a role in anxiety.

Natural opioid enkephalin, which is highly expressed in the brain's amygdala, has been shown to promote fear, anxiety, and aggression in mice in experiments. On the contrary, these behaviors are reduced when enkephalin levels are raised or reduced during treatment.

This action supports enkephalin's anxiety-inhibiting properties. Still, when it attaches to distinct receptors in the amygdala, it may have opposite effects, depending on which one it binds to.

Photo by Lachlan Dempsey on Unsplash

News Editor - TravelDailyNews Media Network | + Posts

Tatiana is the news coordinator for TravelDailyNews Media Network (traveldailynews.gr, traveldailynews.com and traveldailynews.asia). Her role includes monitoring the hundreds of news sources of TravelDailyNews Media Network and skimming the most important according to our strategy.

She holds a Bachelor's degree in Communication & Mass Media from Panteion University of Political & Social Studies of Athens and she has been editor and editor-in-chief in various economic magazines and newspapers.

26/01/2023
25/01/2023
24/01/2023
23/01/2023
20/01/2023
19/01/2023